About 2 600 reports

  • GLOBAL CANCER BIOMARKERS MARKET, BY CANCER TYPE
  • NORTH AMERICA: CANCER BIOMARKERS MARKET, BY CANCER TYPE,

“Global cancer biomarkers market projected to grow at CAGR of 12.2%” The global cancer biomarkers market is projected to reach USD 20.48 billion by 2022 from USD 11.53 billion in 2017, at a CAGR of 12.2% from 2017 to 2022. Over the years, the cancer biomarkers market has evolved significantly owing to the rising prevalence...

  • Cancer
  • North America
  • United States
  • World
  • Market Size
  • RISING INCIDENCE OF LUNG CANCER
  • LUNG CANCER LIQUID BIOPSY MARKET IN APAC

About Lung Cancer Liquid Biopsy A liquid biopsy helps to identify free-floating tumor DNA (also known as circulating DNA) within the blood sample of a patient. Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor (EGFR) mutation and other identified mutations, which are responsible for lung cancer. It...

  • Cancer
  • Biocept, Inc.
  • Exosome Diagnostics, Inc.
  • F. Hoffmann-La Roche Ltd.
  • QIAGEN N.V.
  • Bladder cancer
  • Economic burden of bladder cancer

About Bladder Cancer Therapeutics The bladder is an organ located in the lower abdominal region near the pelvic bones and acts as a reservoir of urine. A bladder cancer is characterized by the abnormal cell growth in the bladder, which impairs the proper functioning of urinary system. Majority of bladder cancer develops in the...

  • Cancer
  • Bristol-Myers Squibb Company
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • 6.2.2 Breast Cancer Liquid Biopsy Market & Forecast
  • 6.2.1 Lung Cancer Liquid Biopsy Market & Forecast

The global liquid biopsy market is expected to surpass US$ 5 Billion mark by 2025. Liquid biopsy is a non-invasive technology that detects molecular biomarkers using liquid sample without the need for costly or invasive procedures. The abilities of liquid biopsy like, easy and minimal invasiveness, early cancer diagnosis & detection, characterization...

  • Cancer
  • World
  • Forecast
  • Market Size
  • MDxHealth SA
  • BREAST CANCER: OVERVIEW
  • TREATMENT REGIMEN FOR BREAST CANCER

About Breast Cancer mAbs Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer. The HER-2 protein, present on the surface of normal breast cells, affects the growth of the malignant cells. The uncontrolled synthesis of this protein stimulates...

  • Cancer
  • Amgen Inc.
  • Biocon Limited
  • Mylan Inc.
  • Roche Group
  • 1.1 BREAST CANCER
  • BREAST CANCER BY TYPES

‘Breast cancer’ defines a malignant tumor that has developed from cells in the breast. Some breast cancers are called in situ as they are confined within the ducts (ductal carcinoma in situ or DCIS) or lobules (lobular carcinoma in situ or LCIS) where they originated. Although, less commonly, breast cancer can also...

  • Cancer
  • World
  • Market Size
  • AbbVie Inc.
  • AstraZeneca PLC
  • Cancer statistics
  • Market segmentation by cancer type

About the Cancer Diagnostic Devices Market An increase in any particular internal and external factor can lead to cancer. Currently, the demand for cancer therapy and research in complex molecular tumor diagnostics is high. Researchers are using automated solutions to isolate genetic materials from small tissue samples. The complex...

  • Cancer
  • World
  • Agilent Technologies, Inc.
  • QIAGEN N.V.
  • Roche Group
  • TREATMENT GUIDELINES FOR PROSTATE CANCER
  • AJCC STAGING OF PROSTATE CANCER

PharmaPoint: Prostate Cancer - Global Drug Forecast and Market Analysis to 2026 Summary Prostate cancer (PCa) is the second most common cancer in men worldwide, after skin cancer. It accounts for 12% of all the cancers diagnosed in men, and thus represents a huge burden on healthcare systems. While...

  • Cancer
  • Hormone
  • Prostate Cancer
  • Therapy
  • PROVENGE group
  • Cancer involving bone marrow
  • Effect of high cost of cancer drugs on cancer supportive care market

About Cancer Supportive Care Cancer supportive care drugs are used for the treatment of adverse effects caused due to the cancer treatment such as chemotherapy-induced anemia, CINV, bone metastasis, cancer pain, and others. Various class of drugs are used as cancer supportive care drugs. Some of the major drug class that involves...

  • Blood Disease
  • Cancer
  • Amgen Inc.
  • Helsinn Group
  • Merck & Co., Inc.
  • CANCER GENE THERAPY MARKET IN APAC
  • Identifying factors impacting market growth

About Cancer Gene Therapy Cancer gene therapy is the treatment of cancer through gene therapy. The therapy uses genetically engineered vectors mostly viruses to deliver a gene into the individual’s body. It can be used for both the prevention and treatment of disease. The major therapies used for the treatment are oncolytic virotherapy,...

  • Cancer
  • World
  • Forecast
  • Market Size
  • Celgene Corporation
  • Global Cervical Cancer Diagnostics
  • B: Cervical Cancer Flowchart

Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of global cervical cancer diagnostics market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies),...

  • Cancer
  • World
  • Market Size
  • Abbott Laboratories, Inc.
  • Hologic, Inc.
  • BREAST CANCER
  • BREAST CANCER

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2025 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. Today, HER2-positive breast cancer patients are living longer with their disease, thanks to established...

  • Cancer
  • Forecast
  • Novartis AG
  • Pfizer Inc.
  • Roche Group
  • Blood Cancer
  • CANCER BY TYPES

Scope of the Report The report entitled “Global Cancer Diagnostic Market with Focus on Lung and Breast Cancer (2016-2020)”, provides analysis of the global cancer diagnostics market and the US cancer diagnostics market, with detailed analysis of market size and growth, penetration and market share. The report also provides the...

  • Cancer
  • Lung Cancer
  • World
  • Market Size
  • MetaStat, Inc.
  • Cervical Cancer Key Statistics
  • 19.2 South Korea Cervical Cancer Mortality

Cervical cancer is one of the most prevalent forms of cancer affecting women all over the world. In most cases, the disease is attributed to genital Human Papilloma Virus (HPV) infection. As cervical cancer is a disease with long latent period, early detection and treatment of precancerous lesions is known to be highly effective...

  • Cancer
  • Cervical Cancer
  • Medical Device
  • Sexually Transmitted Disease
  • Forecast
  • Common Protein Cancer Biomarkers
  • 5.2 APPLICATIONS OF CANCER BIOMARKERS

Cancer Biomarkers Market The market for Global Cancer Biomarkers is highly dynamic. The Cancer Biomarkers market is expected to reach USD XXmillion by 2022 from USD XXmillion in 2016, at a CAGR of XX%. Biomarkers are chemical, physical or biological parameters which can be used to indicate disease states. Oncology biomarkers offers...

  • Cancer
  • North America
  • United States
  • World
  • Market Size
  • PROGNOSIS FOR COLON AND RECTAL CANCER
  • STAGE DEFINITIONS FOR COLORECTAL CANCER

PharmaPoint: Colorectal Cancer - Global Drug Forecast and Market Analysis to 2025 Summary Colorectal Cancer (CRC) Market, considering the sales of both branded treatments and generic chemotherapy, is expected to experience a moderate growth between 2015 and 2025. The main drivers of growth will be the expected increased...

  • Cancer
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.
  • TYPES OF LUNG CANCER
  • LUNG CANCER THERAPEUTICS MARKET IN EMEA

About Lung Cancer Therapeutics Lung cancer is a common cause of mortality and morbidity in both developed and developing countries. Smoking is a major cause of lung cancer, though it also occurs in non-smokers. Lung cancer can be categorized into two major types, namely NSCLC and SCLC. NSCLC is the commonest type of lung cancer and constitutes...

  • Cancer
  • AstraZeneca PLC
  • Celgene Corporation
  • Eli Lilly & Co.
  • Hoffmann-La Roche Inc.
  • Prostate cancer
  • TYPES OF PROSTATE CANCER

About Prostate Cancer Drugs Prostate cancer is the cancer of prostate gland. According to CDC, it is one of the leading cause of cancer death in men across the races in the US. According to the Urology Care Foundation, globally, one in seven men will be diagnosed with the disease. About one in 35 men die due to prostate cancer. Growth in...

  • Cancer
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Sanofi S.A.
  • Cervical cancer: An overview
  • Cervical cancer cases comparison in North-Americas and Africa

About Cervical Cancer Diagnostic Testing The global cervical cancer diagnostic testing market is growing steadily, primarily due to the availability and awareness of the programs in the developed countries. This test enables women aged 21 years and above to get screened, making most of the pre-cancerous lesions identifiable at stages...

  • Cancer
  • Cervical Cancer
  • Sexually Transmitted Disease
  • Hologic, Inc.
  • QIAGEN N.V.
  • MOLECULAR SUBTYPES OF BREAST CANCER
  • PROGNOSIS FOR BREAST CANCER

PharmaPoint: HER2-Negative/HR+ and Triple Negative Breast Cancer - Global Drug Forecast and Market Analysis to 2025 Summary Human Epidermal growth factor Receptor type 2 (HER2-) breast cancer is the second most common cancer in the world and the most common cancer in women worldwide. HER2-negative breast cancer...

  • Cancer
  • Market Size
  • Novartis AG
  • Pfizer Inc.
  • Roche Group
  • 2.2.1 Cancer Pain
  • Cancer Supportive Care Market, Global, Pipeline for Cancer Supportive Care

Global Cancer Supportive Care Therapeutics Market to 2022 - Patent Expirations Create Opportunities for Biosimilars in the Chemotherapy Induced Anemia and Neutropenia Markets Summary Cancer is a disease characterized by abnormal cell growth and uncontrolled proliferation caused by a series of mutations that result in the...

  • Cancer
  • World
  • Amgen Inc.
  • Daiichi Sankyo Company
  • Eli Lilly & Co.
  • Incidences of Cancer
  • Major Cancer Among Women

Executive Summary Rising incidences of cancer owing to unhealthy food habits and sedentary lifestyle coupled with the growing technological advancements has resulted in the growth of global cancer diagnostics market Market for cancer diagnostics is growing at a steady pace due to higher incidences of cancer among the population,...

  • Cancer
  • Market Size
  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company, Ltd
  • 11.1 INCREASING INCIDENCE OF CANCER
  • 8. Global Cancer Vaccines - Funding

The cancer industry is one of the most lucrative business worldwide. Cancer vaccines are a viable option for treating many types of cancers which in the present day do not have effective treatments. Cancer vaccines can be broadly classified into two segments: prophylactic and therapeutic vaccines. Prophylactic vaccines are used for the prevention...

  • Cancer
  • World
  • Altor BioScience Corporation
  • GlobeImmune, Inc.
  • Merck & Co., Inc.
  • CANCER AUSTRALIA
  • BREAST CANCER NETWORK AUSTRALIA

Get 10% Free Customization in this Report Breast Cancer Screening Market is expected to be more than US$ 20 Billion by 2022. Breast cancer is the 2nd most common cancer among the women in the world. Number of breast cancer cases in less developed regions is higher than developed regions. Breast cancer mammography screening population...

  • Breast Cancer
  • Cancer
  • Southeast Asia
  • Western Europe
  • Forecast
  • HER2-NEGATIVE BREAST CANCER MARKET IN AMERICAS 2014-2019 ($ MILLIONS)
  • HER2-NEGATIVE BREAST CANCER MARKET IN APAC 2014-2019 ($ MILLIONS)

About HER2-negative breast cancer HER2-negative breast cancer is a subtype of breast cancer and is the condition when the HER2 is expressed less in the tumor. According to the American Society of Clinical Oncology, most of the patients with breast cancer are known to have HER2-negative breast cancer. HER2-negative breast cancer patients...

  • Cancer
  • Alcon, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Pfizer Inc.
  • 9.1.3 INVESTIGATIONAL NEW DRUG/CLINICAL TRIAL AUTHORIZATION-FILED
  • CRC THERAPEUTICS MARKET, PROGNOSIS FOR CRC

Cancer Letters; ##(##): ##-## Globocan (2012).

  • Cancer
  • Therapy
  • World
  • Market Size
  • Merck & Co., Inc.
  • MM, Sources of CRC Cancer Stage at Diagnosis
  • presents the sources used to forecast cancer stage at diagnosis distribution of CRC cases in the 8MM.

EpiCast Report: Colorectal Cancer - Epidemiology Forecast to 2025 Summary Colorectal cancer (CRC) is a cancer that starts in the colon or the rectum (ACS, 2016). CRC is one of the most common types of cancers diagnosed; it is the third most common cancer among men and the second most common in women, worldwide (Ferlay...

  • Cancer
  • China
  • United States
  • Forecast
  • Cancer Epidemiology Group
  • CANCER AUSTRALIA
  • NATIONAL BREAST CANCER FOUNDATION

Breast cancer is one of the major cause of mortality among women in both the developed and developing world. Early detection remains the primary defense available to patients in preventing the development of life-threatening breast cancer. Breast cancer screening is the regular examination of a woman's breasts to find breast cancer early....

  • Cancer
  • Eastern Europe
  • Northern Europe
  • Western Europe
  • Forecast
  • Bladder Cancer Risk Factors
  • lists two of the major risks factors for bladder cancer.

EpiCast Report: Bladder Cancer - Epidemiology Forecast to 2025 Summary Bladder cancer is a commonly diagnosed cancer and causes significant numbers of cancer deaths worldwide (Parkin, 2008; Ploeg et al., 2009). The major risk factors for bladder cancer are exposure to smoking and occupational risk factors such as exposure...

  • Cancer
  • Japan
  • United Kingdom
  • United States
  • Forecast
  • 2.5.3 Age-Standardized Diagnosed Incidence of Ovarian Cancer
  • 2.5 EPIDEMIOLOGICAL FORECAST FOR OVARIAN CANCER (2015-2025)

EpiCast Report: Ovarian Cancer - Epidemiology Forecast to 2025 Summary Ovarian cancer (International Classification of Diseases, 10th Revision [ICD-10] code C56) and cancer of the fallopian tubes and other uterine adnexa (ICD-10 C57) are leading causes of cancer mortality in women (ACS, 2016; CDC, 2016). Cancer of the...

  • Cancer
  • Japan
  • United States
  • World
  • Forecast